Factors related with adiponectinemia in obese and normal-weight women and with its variation in weight loss programs

Obesity Facts

Volumn 6, Issue 2, 2013, Pages 124-133

  Silva Nunes, José ^a,b   Oliveira, Ana ^b   Duarte, Leone ^c,d   Barradas, Margarida ^c   Melão, Alice ^b   Brito, Miguel ^b   Veiga, Luisa ^b  

^a HOSPITAL CURRY CABRAL   (Portugal)

^b INSTITUTO POLITÉCNICO DE LISBOA   (Portugal)

^c Portuguese Diabetes Association   (Portugal)

^d HOSPITAL DA LUZ   (Portugal)

Author keywords

Adipokines; Adiponectin; Bariatric surgery; Lifestyle factors; Obesity; Weight loss

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; ORAL CONTRACEPTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADIPONECTINEMIA; ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DISORDERS OF HORMONE METABOLISM; FEMALE; HUMAN; MACRONUTRIENT; MAJOR CLINICAL STUDY; OBESITY; ORAL CONTRACEPTION; PREMENOPAUSE; PRIORITY JOURNAL; SMOKING; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; AGED; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; DIET; FOOD INTAKE;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; ADULT; BARIATRIC SURGERY; BODY COMPOSITION; DIET; DIETARY CARBOHYDRATES; FEMALE; HUMANS; INTERLEUKIN-6; MICRONUTRIENTS; MIDDLE AGED; OBESITY; REFERENCE VALUES; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS; YOUNG ADULT;

EID: 84875845471     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000350664     Document Type: Article

References (33)

1. Tilg H, Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783. (Pubitemid 44453463)
2. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451. (Pubitemid 40686653)
3. Scherer PE: Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-1545. (Pubitemid 44324105)
4. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A: Vascular effects of adiponectin: Molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008; 114: 361-374. (Pubitemid 351397385)
5. Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, Fox CS, O'Donnell CJ, Cupples LA, Meigs JB: Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: The Framingham Offspring Study. Diabetes 2008; 57: 3353-3359.
6. Fredriksson J, Carlsson E, Orho-Melander M, Groop L, Ridderstråle M: A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects. Int J Obes (Lond) 2006; 30: 226-232. (Pubitemid 43237675)
7. Han SH, Sakuma I, Shin EK, Koh KK: Antiatherosclerotic and anti-insulin resistance effects of adiponectin: Basic and clinical studies. Prog Cardiovasc Dis 2009; 52: 126-140.
8. Yamauchi T, Kadowaki T: Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 2008; 32(suppl 7):S13-18.
9. Cook JR, Semple RK: Hypoadiponectinemia-cause or consequence of human 'insulin resistance'? J Clin Endocrinol Metab 2010; 95: 1544-1554.
10. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B: Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285:E527-533. (Pubitemid 37010830)
11. Li L, Yang G, Shi S, Yang M, Liu H, Boden G: The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009; 45: 12-19.
12. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50: 2094-2099. (Pubitemid 33643677)
13. Summer SS, Brehm BJ, Benoit SC, D'Alessio DA: Adiponectin changes in relation to the macronutrient composition of a weight-loss diet. Obesity (Silver Spring) 2011; 19: 2198-2204.
14. Yeung EH, Appel LJ, Miller ER 3rd, Kao WH: The effects of macronutrient intake on total and high-molecular weight adiponectin: Results from the OMNI-Heart trial. Obesity (Silver Spring) 2010; 18: 1632-1637.
15. Schwarz PE, Towers GW, Fischer S, Govindarajalu S, Schulze J, Bornstein SR, Hanefeld M, Vasseur F: Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006; 29: 1645-1650. (Pubitemid 44127594)
16. Ohashi K, Ouchi N, Matsuzawa Y: Adiponectin and hypertension. Am J Hypertens 2011; 24: 263-269.
17. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group: Coronary artery disease association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89. (Pubitemid 36091630)
18. Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S: Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53: 430-434. (Pubitemid 38419183)
19. Xu A, Wang Y, Lam KS, Vanhoutte PM: Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol 2010; 60: 229-255.
20. Antonopoulos AS, Lee R, Margaritis M, Antoniades C: Adiponectin as a regulator of vascular redox state: Therapeutic implications. Recent Pat Cardiovasc Drug Discov 2011; 6: 78-88.
21. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469. (Pubitemid 36577787)
22. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
23. Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139.
24. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P: Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004; 53: 1966-1971. (Pubitemid 38970743)
25. Bergmann S, Siekmeier R: Influence of smoking and body weight on adipokines in middle aged women. Eur J Med Res 2009; 14(suppl 4):21-26.
26. Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I: Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb 2011; 18: 592-595.
27. Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N: Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest 2011; 34: 615-619.
28. Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I: Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb 2010; 17: 1201-1211.
29. Martins C, Strømmen M, Stavne OA, Nossum R, Mårvik R, Kulseng B: Bariatric surgery versus lifestyle interventions for morbid obesity-changes in body weight, risk factors and comorbidities at 1 year. Obes Surg 2011; 21: 841-849.
30. Moschen AR, Molnar C, Geiger S, Graziadei I, Ebenbichler CF, Weiss H, Kaser S, Kaser A, Tilg H: Anti-inflammatory effects of excessive weight loss: Potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut 2010; 59: 1259-1264.
31. Pardina E, Ferrer R, Baena-Fustegueras JA, Rivero J, Lecube A, Fort JM, Vargas V, Catalán R, Peinado-Onsurbe J: Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg 2012; 22: 131-139.
32. Forsythe LK, Wallace JM, Livingstone MB: Obesity and inflammation: The effects of weight loss. Nutr Res Rev 2008; 21: 117-133.
33. Varady KA, Tussing L, Bhutani S, Braunschweig CL: Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism 2009; 58: 1096-1101.